NC

Nara Capital

Europe, Catalonia, Spain, Barcelona

Description

Nara is a purpose-driven investment firm that invests in biotech & life sciences SMEs and startups.

Investor Profile

Nara Capital has made 7 investments, with 2 in the past 12 months and 43% as lead.

Stage Focus

  • Seed (71%)
  • Series Unknown (29%)

Country Focus

  • Spain (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Health Diagnostics
  • Medical Device
  • Medical
  • Biopharma
  • Pharmaceutical
  • Therapeutics
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nara Capital frequently co-invest with?

Clave Mayor
Europe, Navarra, Spain, Pamplona
Co-Investments: 1
BP
Europe, Catalonia, Spain, Mediona
Co-Investments: 1
Invivo Capital Partners
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
Clave Capital
South America, Sao Paulo, Brazil, Jardim Paulista
Co-Investments: 3
NV
Europe, Catalonia, Spain, Barcelona
Co-Investments: 2
EIC Accelerator
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
WA4STEAM
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
JC
Europe, Catalonia, Spain, Badalona
Co-Investments: 1
CI
Europe, Madrid, Spain, Madrid
Co-Investments: 3
Co-Investments: 1

Which angels does Nara Capital often collaborate with?

AH
Europe, Catalonia, Spain, Barcelona
Shared Deals: 1

What are some of recent deals done by Nara Capital?

Heecap

Barcelona, Catalonia, Spain

Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.

Health CareHospitalMedicalMedical Device
SeedDec 9, 2024
Amount Raised: $2,923,847
Gyala Therapeutics

Barcelona, Catalonia, Spain

Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.

BiotechnologyLife ScienceTherapeutics
Series UnknownOct 14, 2024
Affirma Biotech

Barcelona, Catalonia, Spain

Affirma Biotech is a pre-clinical startup which develops host-directed drugs as treatments for chronic and infection diseases.

BiopharmaBiotechnologyLife ScienceMedicalPharmaceutical
Series UnknownFeb 1, 2024
Amount Raised: $1,875,830
MiMARK

Barcelona, Catalonia, Spain

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.

BiotechnologyHealth CareHealth Diagnostics
SeedNov 28, 2023
Amount Raised: $4,220,000
OneChain Immunotherapeutics

Barcelona, Catalonia, Spain

OCI develops therapies for leukaemia based on CAR–T.

BiotechnologyLife Science
SeedJun 22, 2023
Amount Raised: $7,340,197
MiMARK

Barcelona, Catalonia, Spain

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.

BiotechnologyHealth CareHealth Diagnostics
SeedJun 8, 2023
Amount Raised: $1,078,205
Innitius

Derio, Pais Vasco, Spain

Innitius is focus on ultrasound waves technologies development.

Medical Device
SeedFeb 15, 2023
Amount Raised: $1,924,506